Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$107M |
| 2 |
Alibaba
BABA
|
$60.3M |
| 3 |
TSMC
TSM
|
$46.7M |
| 4 |
Henry Schein
HSIC
|
$30.2M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
$24.8M |
Top Sells
| 1 |
Philip Morris
PM
|
$91.6M |
| 2 |
Kellanova
K
|
$57.6M |
| 3 |
Hain Celestial
HAIN
|
$51.6M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$46M |
| 5 |
Microsoft
MSFT
|
$44.5M |
Sector Composition
| 1 | Technology | 26.5% |
| 2 | Healthcare | 15.42% |
| 3 | Communication Services | 11.5% |
| 4 | Consumer Discretionary | 10.57% |
| 5 | Financials | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WOOF
201
DELISTED
VCA Inc.
WOOF
| $15.5M | 0.13% |
229,159
-5,204
| -2% | -$352K |
|
202
Axos Financial
AX
$5.13B
| $15.5M | 0.13% |
874,529
+319,516
| +58% | +$5.66M |
|
203
Protolabs
PRLB
$1.19B
| $15.4M | 0.13% |
267,419
+97,755
| +58% | +$5.63M |
|
204
ePlus
PLUS
$1.89B
| $15.2M | 0.13% |
745,200
+272,264
| +58% | +$5.57M |
|
205
VF Corp
VFC
$5.86B
| $15.1M | 0.13% |
261,489
-23,997
| -8% | -$1.39M |
|
206
Medtronic
MDT
$119B
| $14.9M | 0.12% |
+171,893
| New | +$14.9M |
|
207
Vipshop
VIPS
$8.45B
| $14.9M | 0.12% |
1,334,572
-183,468
| -12% | -$2.05M |
|
208
Walmart
WMT
$801B
| $14.7M | 0.12% |
605,859
-35,868
| -6% | -$873K |
|
209
Charles Schwab
SCHW
$167B
| $14.7M | 0.12% |
582,008
-10,141
| -2% | -$257K |
|
210
Bristol-Myers Squibb
BMY
$96B
| $14.7M | 0.12% |
200,243
+11,309
| +6% | +$832K |
|
|
SAVE
211
DELISTED
Spirit Airlines, Inc.
SAVE
| $14.7M | 0.12% |
326,730
+8,707
| +3% | +$391K |
|
212
Illinois Tool Works
ITW
$77.6B
| $14.7M | 0.12% |
140,780
-5,798
| -4% | -$604K |
|
213
Rexford Industrial Realty
REXR
$10.2B
| $14.5M | 0.12% |
686,069
-110,742
| -14% | -$2.34M |
|
|
HPP
214
Hudson Pacific Properties
HPP
$1.16B
| $14.3M | 0.12% |
490,746
+99,001
| +25% | +$2.89M |
|
215
PVH
PVH
$4.22B
| $14.3M | 0.12% |
151,921
-39,459
| -21% | -$3.72M |
|
216
Occidental Petroleum
OXY
$45.2B
| $14.2M | 0.12% |
188,153
-45,149
| -19% | -$3.41M |
|
217
Infosys
INFY
$67.9B
| $14.2M | 0.12% |
1,589,572
-32,240
| -2% | -$288K |
|
218
Gilead Sciences
GILD
$143B
| $14.2M | 0.12% |
170,126
-21,063
| -11% | -$1.76M |
|
|
DOC
219
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $14.1M | 0.12% |
673,157
-40,045
| -6% | -$841K |
|
220
W.W. Grainger
GWW
$47.5B
| $14.1M | 0.12% |
62,061
+15,277
| +33% | +$3.47M |
|
|
NTUS
221
DELISTED
Natus Medical Inc
NTUS
| $14M | 0.12% |
371,526
+135,589
| +57% | +$5.13M |
|
222
Aaon
AAON
$6.62B
| $13.9M | 0.12% |
760,359
+277,539
| +57% | +$5.09M |
|
223
Amgen
AMGN
$153B
| $13.9M | 0.12% |
91,113
-6,968
| -7% | -$1.06M |
|
224
3M
MMM
$82.7B
| $13.8M | 0.12% |
94,526
-7,023
| -7% | -$1.03M |
|
225
Omnicell
OMCL
$1.47B
| $13.7M | 0.11% |
399,565
+145,997
| +58% | +$5M |
|